CEACAM5 and neoplasm: Similarly, there are no highly sensitive or specific tumour markers for GBC diagnosis in laboratory examination, even though carcinoembryonic antigen (CEA) and carbohydrate antigen 19 − 9 (CA19-9) may be elevated and are often used in the management of GBC patients [6, 7].